Dapagliflozin delays renal fibrosis in diabetic kidney disease by inhibiting YAP/TAZ activation
Lan Feng, Yang Chen, Ni Li, Xiaojuan Yang, Lu Zhou, Huirong Li, Tingting Wang, Man‐Jiang Xie, Hongbao Liu
Topics & Concepts
CTGFDapagliflozinFibrosisMedicineCancer researchKidneyKidney diseaseInternal medicineDiabetic nephropathyEndocrinologyDiabetes mellitusGrowth factorType 2 diabetesReceptorHippo pathway signaling and YAP/TAZChronic Kidney Disease and DiabetesRenal Diseases and Glomerulopathies